AKT1 and diabetic cardiomyopathy: A recent study has found that aldehyde dehydrogenase 2 (ALDH2) can activate the PI3K/AKT/mTOR pathway to alleviate ischemia and reperfusion injury in diabetic cardiomyopathy (44).